Overview
Dosimetry for radiopharmaceutical therapies is increasingly common across the globe, but questions still linger over how to use this information when making clinical decisions. Dr. Ravi Patel, MD, PhD from the University of Pittsburgh Medical Center explores these questions from the perspective of a radiation oncologist. Using illustrative patient examples, he'll show how dosimetry informs treatment decisions alongside other clinical biomarkers.
Dr. Patel will also detail his team’s practical approach to radiopharmaceutical therapy dosimetry, including how work is divided between team members. Finally, he’ll touch on reimbursement and the medical justification for the use of dosimetry in theranostics.
In this webinar, you'll learn how:
- Dosimetry may be used alongside other clinical biomarkers to inform treatment decisions such as alternate therapies, treatment holidays, and the number of therapy cycles.
- Single-timepoint dosimetry compares to multi-timepoint dosimetry.
- Reimbursement for the work involved with dosimetry can be justified in the United States.
Speakers
Ravi Patel, MD, PhD
University of Pittsburgh Medical Center
David Mirando
Product Manager | MIM Software, a GE HealthCare Company
